Matthias Kneussel Selected Research

Matthias Kneussel Research Topics

2	Hearing Loss (Hearing Impairment) 01/2022 - 11/2017
2	Seizures (Absence Seizure) 02/2015 - 12/2002
1	Autistic Disorder (Autism) 04/2024
1	Gliosis 01/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Autism Spectrum Disorder 01/2023
1	Mental Disorders (Mental Disorder) 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Pathologic Processes 01/2023
1	Wounds and Injuries (Trauma) 01/2023
1	Tauopathies 01/2022
1	Deafness (Deaf Mutism) 01/2022
1	Spastic Paraplegia Type 4 01/2020
1	Memory Disorders (Memory Loss) 01/2020
1	Hereditary Spastic Paraplegia 01/2020
1	Neoplasms (Cancer) 11/2018
1	Ovarian Neoplasms (Ovarian Cancer) 11/2018
1	Disease Progression 11/2018
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2018
1	Motor Neuron Disease (Primary Lateral Sclerosis) 11/2016
1	Nervous System Diseases (Neurological Disorders) 01/2016
1	Multiple Sclerosis 12/2012
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2012
1	Cerebellar Ataxia (Dysmetria) 09/2009
1	Molybdenum cofactor deficiency 12/2002

3	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2017
2	TubulinIBA 01/2022 - 01/2020
2	SpastinIBA 01/2020 - 11/2016
2	KinesinsIBA 01/2020 - 01/2016
2	EnzymesIBA 11/2016 - 12/2002
1	Phosphotransferases (Kinase)IBA 04/2024
1	Fibronectins (Fibronectin)IBA 01/2023
1	Cell Adhesion MoleculesIBA 01/2023
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2023
1	Sulpiride (neogama)IBA 01/2023
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2023
1	Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA 01/2023
1	QuinpiroleIBA 01/2023
1	F-actin-binding proteinsIBA 01/2022
1	cyclonite (RDX)IBA 01/2022
1	radixinIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	Cytoskeletal ProteinsIBA 11/2018
1	PrionsIBA 01/2018
1	CationsIBA 12/2012
1	GABA-A Receptors (GABA(A) Receptor)IBA 09/2009
1	gamma-Aminobutyric Acid (GABA)IBA 09/2009
1	Sulfite OxidaseIBA 12/2002
1	molybdopterin (molybdenum cofactor)IBA 12/2002

1	Injections 02/2015
1	Therapeutics 12/2002